Skip to main content

Health condition · Clinically reviewed

Hepatobiliary disease, the liver, biliary tract, gallbladder and pancreas explained.

A hub guide to the family of conditions that share a common outlet at the liver and biliary tree. Patterns of injury, modern assessment, and the treatment paths behind each.

A radiographer guides a patient onto the bed of an advanced 3 Tesla MRI scanner in a London imaging suite

Why trust this guide

  • 01

    Clinically reviewed

    Written by our editorial team and reviewed by a registered UK clinician before publication.

  • 02

    Sourced from guidance

    Checked against BSG, EASL, NICE and peer-reviewed hepatology sources listed at the end.

  • 03

    Current for 2026

    Reflects modern UK practice including MASLD terminology, FibroScan pathways and transplant referral thresholds.

Key facts

Hepatobiliary disease at a glance.

The scope of the specialty, the way clinicians pattern-match the injury, and the tests and referrals that follow.

  • What it covers

    Diseases of the liver, biliary tract, gallbladder and, by convention, the exocrine pancreas that shares its ductal outlet.

  • Main patterns

    Hepatocellular, cholestatic, infiltrative, vascular, neoplastic, biliary and structural. LFT pattern often points the way.

  • Cirrhosis

    The common end-stage of many chronic liver diseases, with portal hypertension, ascites, varices and encephalopathy as complications.

  • MASLD

    Metabolic dysfunction-associated steatotic liver disease is now the most common chronic liver condition in the UK.

  • Key test

    FibroScan (transient elastography) is the workhorse non-invasive fibrosis assessment in modern hepatology clinics.

  • When to refer

    Persistently abnormal LFTs, imaging findings, cirrhosis, jaundice, or any suspected liver or biliary cancer warrant specialist review.

Why this guide matters

Different diseases, one integrated approach.

The liver and biliary tract share their anatomy, their bloods, and often their treating teams. Grouping them makes the pathway easier to navigate.

  • Pattern first, cause second

    Reading the LFT and imaging pattern narrows the differential before any expensive test is ordered.

  • Fibrosis is the endpoint

    Whatever the driver, the outcome that matters most is how much scarring has developed. Modern practice measures that non-invasively.

  • Multidisciplinary by design

    Cancer, transplantation and complex biliary disease sit within specialist commissioned MDTs, not single-clinician clinics.

Types

The eight families of hepatobiliary disease.

A working taxonomy that mirrors how hepatologists and HPB surgeons actually organise the field.

  • Hepatocellular

    Viral hepatitis (see /conditions/hepatitis-b/, /conditions/hepatitis-c/ and /conditions/hepatitis-a/), autoimmune hepatitis, alcohol-related disease, MASLD and MASH, and drug-induced liver injury.

  • Cholestatic

    Primary biliary cholangitis, primary sclerosing cholangitis, secondary biliary cirrhosis, and drug-induced cholestasis.

  • Infiltrative

    Haemochromatosis (see /conditions/hemochromatosis/), Wilson disease, alpha-1 antitrypsin deficiency and hepatic amyloidosis.

  • Vascular

    Budd-Chiari syndrome, portal vein thrombosis and hepatic congestion from right heart disease.

  • Neoplastic

    Hepatocellular carcinoma (see /conditions/hepatocellular-carcinoma/), cholangiocarcinoma (see /conditions/hilar-cholangiocarcinoma/), gallbladder cancer and hepatic metastases.

  • Cirrhosis

    The shared end-stage, with portal hypertension, ascites, varices and hepatic encephalopathy (see /conditions/hepatic-encephalopathy/) as complications.

  • Biliary

    Gallstones, choledocholithiasis, ascending cholangitis and acute cholecystitis - the bread and butter of general HPB clinics.

  • Structural

    Polycystic liver disease and Caroli disease, where the biliary tree is congenitally malformed.

How the diagnosis is made

From abnormal bloods to a working diagnosis.

The staged pathway a UK GP, hepatologist or HPB surgeon will usually follow, in a broadly predictable order.

  1. 01

    Assessing

    History and pattern of LFTs

    The story matters. Alcohol, medication, metabolic risk, family history and travel shape the differential before any test is run.

  2. 02

    Assessing

    Hepatocellular versus cholestatic

    ALT and AST rising out of proportion to ALP suggest hepatocellular injury. ALP and GGT dominance points towards a cholestatic or biliary process.

  3. 03

    Assessing

    Liver screen

    Viral serology, autoimmune profile, ferritin and iron studies, caeruloplasmin, alpha-1 antitrypsin, immunoglobulins and a lipid and glycaemic panel.

  4. 04

    Confirming

    Ultrasound and FibroScan

    Ultrasound gives a first look at the liver, gallbladder and biliary tree. FibroScan quantifies fibrosis and steatosis without a biopsy in most patients.

  5. 05

    Confirming

    MRCP and cross-sectional imaging

    MRCP is the modern non-invasive gold standard for the biliary tree. CT and MRI characterise focal liver lesions and vascular anatomy.

  6. 06

    Planning

    Specialist and MDT review

    Complex disease, cirrhosis, focal lesions and transplant candidacy are handled through hepatology, HPB surgery and specialist commissioned MDTs.

  7. 07

    Planning

    Biopsy when it changes the plan

    Reserved for cases where non-invasive tests cannot answer the question, or where histology will change management.

Typical timeline: a first abnormal LFT to a settled hepatology plan within a few weeks.

Symptoms

What hepatobiliary disease can look like.

From silent LFT abnormalities to jaundice, itch, pain and the classic complications of cirrhosis. The features that shape urgency.

  • Jaundice

    Yellow sclerae and skin from a rising bilirubin. Painless jaundice is a red flag for pancreatic or biliary cancer until proven otherwise.

  • Pruritus

    Cholestatic itch, often worse at night and on the palms and soles, is characteristic of PBC, PSC and biliary obstruction.

  • Right upper quadrant pain

    Colicky pain suggests gallstones. Constant tender pain with fever points to cholecystitis or cholangitis.

  • Fatigue and metabolic features

    Persistent fatigue is common across chronic liver disease and is a hallmark presentation of PBC and MASLD.

  • Swelling and ascites

    Leg oedema and abdominal distension from ascites signal decompensated cirrhosis and portal hypertension.

  • Confusion and encephalopathy

    Reversed sleep patterns, poor concentration and asterixis point to hepatic encephalopathy in advanced liver disease.

  • Haematemesis and melaena

    Vomiting blood or passing black stools may indicate bleeding oesophageal or gastric varices. Emergency assessment is essential.

  • Red flag - painless jaundice

    Painless progressive jaundice, weight loss and a palpable gallbladder need urgent same-week imaging and specialist referral.

Treatment

How hepatobiliary disease is treated in the UK.

Treatment starts with the underlying cause and adds endoscopic, surgical, oncological and transplant options as the disease demands.

  • Treat the driver

    Antivirals for hepatitis B and C, weight loss and metabolic control for MASLD, alcohol reduction, immunosuppression for autoimmune hepatitis.

  • Ursodeoxycholic acid

    First-line therapy in PBC, with obeticholic acid or fibrates considered for inadequate biochemical response under specialist care.

  • Iron and copper removal

    Venesection in haemochromatosis and chelation or zinc therapy in Wilson disease, guided by monitoring bloods.

  • Endoscopic biliary drainage

    ERCP with stenting or stone extraction is the mainstay for choledocholithiasis, benign strictures and palliation of malignant obstruction.

  • Cholecystectomy

    Laparoscopic gallbladder removal for symptomatic gallstones, acute cholecystitis after stabilisation, and gallstone pancreatitis.

  • Variceal and ascites care

    Endoscopic banding, non-selective beta-blockers, paracentesis, diuretics and TIPS in selected patients with portal hypertension.

  • Oncological therapy

    Resection, ablation, transarterial chemoembolisation, systemic therapy and, for eligible HCC patients, transplantation within accepted criteria.

  • Transplant referral

    Considered in decompensated cirrhosis, acute liver failure, eligible HCC and selected cholestatic diseases through a specialist commissioned service.

Key assessment and treatment pathways include the FibroScan clinic for fibrosis, MRI liver iron quantification for infiltrative disease, and the liver transplant clinic for advanced disease.

What this guide is based on

The sources behind every claim on this page.

UK and international specialist society guidance, current at the time of last review.

Key references

Guidelines and standards we relied on.

A quiet reminder

This guide is for information, not medical advice.

Your GP or hepatologist knows your history and can tell you which parts apply to you. If in doubt, get seen.

  • British Society of Gastroenterology (BSG). Guidelines on the management of abnormal liver blood tests.

  • European Association for the Study of the Liver (EASL). Clinical practice guidelines on cirrhosis, cholestatic and metabolic liver disease.

  • NICE. Cirrhosis in over 16s: assessment and management (NG50) and gallstone disease (CG188).

  • AASLD practice guidance on HCC, PBC and PSC. UK NHS Blood and Transplant liver transplant selection policies.

Red flags

When hepatobiliary disease needs urgent attention.

Some features cannot wait. These are the presentations where hours and days genuinely change the outcome.

  • Painless progressive jaundice

    Suggests malignant biliary or pancreatic obstruction. Needs urgent imaging within days and rapid specialist referral.

  • Ascending cholangitis

    Fever, rigors, jaundice and right upper quadrant pain (Charcot triad) is a surgical emergency needing intravenous antibiotics and drainage.

  • Acute liver failure

    Jaundice, coagulopathy and encephalopathy in a previously well liver is a transplant-unit emergency, most often from paracetamol.

  • Variceal bleeding

    Haematemesis or melaena in known or suspected liver disease requires immediate hospital assessment with endoscopy and vasoactive therapy.

  • Spontaneous bacterial peritonitis

    Fever, abdominal pain or new encephalopathy in a patient with ascites needs urgent diagnostic ascitic tap and antibiotics.

  • Hepatic encephalopathy

    New confusion or drowsiness in cirrhosis needs same-day medical review to identify precipitants and start lactulose or rifaximin.

  • Suspected HCC or cholangiocarcinoma

    A new focal liver lesion or biliary stricture on imaging warrants urgent specialist MDT review, not watchful waiting.

  • Wilson disease in a young patient

    Unexplained hepatitis with neurological or psychiatric features in someone under 40 needs caeruloplasmin, urinary copper and specialist input.

  • Paracetamol overdose

    Any deliberate or staggered paracetamol ingestion needs urgent assessment for N-acetylcysteine, even when symptoms are absent.

Living with it

A treatable specialty, with real levers.

Four everyday levers that make the biggest difference across almost every hepatobiliary condition - alcohol, metabolic health, medicines and vaccines.

A quiet reminder

The liver is remarkably forgiving, but not infinitely so.

Early, sustained change is worth more than any single test result. Small habits, kept for months, compound.

  1. 01 Alcohol

    Rethink the relationship

    Alcohol accelerates almost every chronic liver disease. Reducing or stopping is often the single most useful thing a patient can do.

  2. 02 Metabolic

    Weight, blood sugar and lipids

    MASLD responds to sustained weight loss of five to ten per cent, tight glycaemic control and treatment of associated cardiometabolic risk.

  3. 03 Medicines

    Check every drug and supplement

    Herbal supplements, high-dose paracetamol and some prescribed drugs can injure the liver. Bring a full list to every appointment.

  4. 04 Vaccines

    Protect the liver

    Hepatitis A and B vaccination is recommended in most chronic liver disease. Annual influenza and pneumococcal vaccines matter more once cirrhotic.

Frequently asked

Everything we get asked about hepatobiliary disease.

Quick answers on LFT patterns, fibrosis assessment, gallstones, cirrhosis and transplantation.

  • What does hepatobiliary disease actually mean?

    It is an umbrella term for disorders of the liver, the bile ducts and the gallbladder. Because the pancreatic and bile ducts share an outlet at the ampulla of Vater, pancreatic disease is often discussed alongside biliary disease in the same clinics.

  • What is the difference between hepatocellular and cholestatic liver disease?

    Hepatocellular disease injures liver cells directly, giving a rise in ALT and AST. Cholestatic disease impairs bile flow at the level of the bile canaliculi, ducts or larger biliary tree, and shows a predominant rise in ALP and GGT with itch and, if severe, jaundice.

  • How is liver fibrosis assessed without a biopsy?

    Most UK patients are now assessed with FibroScan, which measures liver stiffness by transient elastography, alongside blood-based scores such as FIB-4 and ELF. Biopsy is reserved for cases where these do not answer the clinical question.

  • When are gallstones actually a problem?

    Most gallstones cause no symptoms and need no treatment. They matter when they cause biliary colic, cholecystitis, choledocholithiasis, cholangitis or gallstone pancreatitis, at which point cholecystectomy and, sometimes, ERCP are considered.

  • What are the warning signs of decompensated cirrhosis?

    The classic four are ascites, variceal bleeding, hepatic encephalopathy and jaundice. Any of these in known or suspected cirrhosis should trigger urgent hospital assessment and a hepatology opinion.

  • Who should be considered for liver transplantation?

    Patients with decompensated cirrhosis, acute liver failure, hepatocellular carcinoma within accepted size and number criteria, and some cholestatic diseases with intractable symptoms are considered. Referral is through a specialist commissioned service and depends on eligibility rather than ability to pay.

Related content

Keep reading.

Pulse Healthcare concierge

Send us your enquiry

A concierge service for UK private healthcare. We match you with the best vetted clinics and consultants in our network - they then contact you directly.

So we can match you to the right clinician close to you.

We reply to every enquiry within 24 hours (Mon–Fri). Confidential - your details are never shared outside our vetted consultant network.